Rare germline pathogenic variants identified by multigene panel testing and the risk of aggressive prostate cancer - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Cancers Année : 2021

Rare germline pathogenic variants identified by multigene panel testing and the risk of aggressive prostate cancer

Tú Nguyen-Dumont
James G. Dowty
Robert Jeffrey Macinnis
  • Fonction : Auteur
Jason A. Steen
Paul Lacaze
John J. Mcneil
Graham G. Giles

Résumé

While gene panel sequencing is becoming widely used for cancer risk prediction, its clinical utility with respect to predicting aggressive prostate cancer (PrCa) is limited by our current understanding of the genetic risk factors associated with predisposition to this potentially lethal disease phenotype. This study included 837 men diagnosed with aggressive PrCa and 7261 controls (unaffected men and men who did not meet criteria for aggressive PrCa). Rare germline pathogenic variants (including likely pathogenic variants) were identified by targeted sequencing of 26 known or putative cancer predisposition genes. We found that 85 (10%) men with aggressive PrCa and 265 (4%) controls carried a pathogenic variant (p < 0.0001). Aggressive PrCa odds ratios (ORs) were estimated using unconditional logistic regression. Increased risk of aggressive PrCa (OR (95% confidence interval)) was identified for pathogenic variants in BRCA2 (5.8 (2.7–12.4)), BRCA1 (5.5 (1.8–16.6)), and ATM (3.8 (1.6–9.1)). Our study provides further evidence that rare germline pathogenic variants in these genes are associated with increased risk of this aggressive, clinically relevant subset of PrCa. These rare genetic variants could be incorporated into risk prediction models to improve their precision to identify men at highest risk of aggressive prostate cancer and be used to identify men with newly diagnosed prostate cancer who require urgent treatment.
Fichier principal
Vignette du fichier
cancers-13-01495.pdf (608.79 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03199072 , version 1 (30-05-2022)

Licence

Identifiants

Citer

Tú Nguyen-Dumont, James G. Dowty, Robert Jeffrey Macinnis, Jason A. Steen, Moeen Riaz, et al.. Rare germline pathogenic variants identified by multigene panel testing and the risk of aggressive prostate cancer. Cancers, 2021, 13 (7), pp.1495. ⟨10.3390/cancers13071495⟩. ⟨hal-03199072⟩
29 Consultations
55 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More